When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALNY - Alnylam Pharmaceuticals Non-GAAP EPS of -$1.69 misses by $0.43 revenue of $258.54M beats by $24.92M
Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals press release (NASDAQ:ALNY): Q4 Non-GAAP EPS of -$1.69 misses by $0.43. Revenue of $258.54M (+58.1% Y/Y) beats by $24.92M. Shares +0.2% PM. Provides 2022 Combined Net Product Revenue Guidance of $900 Million to $1 Billion, in Addition to Collaboration & Royalty Revenue and Operating Expense Guidance, Net revenues from collaborations and royalties $175 million – $225 million.